CPHI & PMEC China 2023: A Global Stage for Pharmaceutical Advancements

CPHI & PMEC China 2023 event banner

This June, the Shanghai New International Expo Center will welcome CPHI & PMEC China, hosting over 3,000 exhibitors and more than 55,000 attendees from over 110 countries. Jenny Leung, Regional Manager of Informa Markets, highlighted the event’s importance in fostering global partnering and addressing the growing international ingredients demand. The co-located events will cover 15 sectors, providing an all-encompassing platform for the pharmaceutical industry.

China’s reputation for API manufacturing has seen a significant 25% improvement, according to the CPHI Annual Survey[2]. This places the country on par with leading European nations like Italy and France. As the world’s largest market for pharmaceutical ingredients and starting materials, China offers immense opportunities for global pharma industry players.

PMEC, the world’s largest pharmaceutical machinery event, will showcase over 1,000 exhibitors, 30% of which are new for 2023. Attendees will have the opportunity to explore a wide range of products and technologies, including laboratory and analytical equipment, tablet compressors, filling machines, and state-of-the-art continuous manufacturing technologies.

The Hosted Buyer Programme will return to CPHI & PMEC China, offering a targeted matchmaking service that connects international attendees with domestic and regional suppliers, fostering international collaborations in the global pharmaceutical landscape.

In addition to the exhibition, CPHI & PMEC China will host over 80 conference sessions, the 12th China-World CEO Summit, the InnoPack Awards China, the China-World Innovation and Development Forum, and International Regulatory Agencies Updates. These sessions aim to facilitate collaboration, innovation, and networking among global pharmaceutical professionals, further bolstering the global pharmaceutical industry’s growth and development.

Author

Leave a Reply

Your email address will not be published.